Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Oligo dT VN

    Oligo dT VN is used for anchored cDNA synthesis. But what does "VN" in the end do? Please help. Thanks.

  • #2
    Oligo dT length is normally 30nt but transcript poly A tail could be longer. Including VN at 3’ end of RT primer enriches for non-poly A region of transcripts and without it RT can be primed in poly A region so cDNA would have A/T homopolymer which in most sequencing applications is undesirable. A side effect of VN inclusion is possible bias in some transcripts conversion to cDNA.

    Comment


    • #3
      'N' is any base, 'V' is either A,C or G. This allows for anchoring at the beginning of the Poly-A tail.

      Comment


      • #4
        why VN, why not just V for oligo dT anchor?

        Why does almost everyone use 3'-VN as the anchor for oligo dT primers rather than using 3'-V?

        The former only has a 1/12 chance of matching a given mRNA, vs. 1/3 for the latter. Plus 1/4 of the former will have T as the N, meaning there's a greater potential for annealing and extension within the polyA tail with VN vs V.

        Only reason I can think of is legacy.

        Thanks!
        Mike

        Comment


        • #5
          I have not done any tests. I guess the assumption is that the oligos will make multiple attempts to hybridize and that a two-base anchor is "stronger" than a single base.

          Comment

          Latest Articles

          Collapse

          • seqadmin
            Understanding Genetic Influence on Infectious Disease
            by seqadmin




            During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

            Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
            09-09-2024, 10:59 AM
          • seqadmin
            Addressing Off-Target Effects in CRISPR Technologies
            by seqadmin






            The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
            08-27-2024, 04:44 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by seqadmin, Today, 06:25 AM
          0 responses
          13 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, Yesterday, 01:02 PM
          0 responses
          12 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 09-18-2024, 06:39 AM
          0 responses
          14 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 09-11-2024, 02:44 PM
          0 responses
          14 views
          0 likes
          Last Post seqadmin  
          Working...
          X